WO1996026681A1 - Infusion bag with injection port - Google Patents
Infusion bag with injection port Download PDFInfo
- Publication number
- WO1996026681A1 WO1996026681A1 PCT/US1996/002580 US9602580W WO9626681A1 WO 1996026681 A1 WO1996026681 A1 WO 1996026681A1 US 9602580 W US9602580 W US 9602580W WO 9626681 A1 WO9626681 A1 WO 9626681A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- infusion
- infusion bag
- injection port
- separator layer
- plug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
Definitions
- the present invention relates to infusion bags for administering infusion liquids to subjects, and paiticulaily to an infusion bag including a novel injection port construction for injecting a substance into the infusion bag.
- Blunt cannulas are now coming into increasing use in place of hypodermic needles in order to reduce the danger of infection by accidental contact with a contaminated needle.
- blunt cannula constructions the device to be penetrated is closed by an elastomeric plug which is preformed with a slit to accommodate the blunt cannula, but which reseals itself after the blunt cannula has been removed.
- An object of the present invention is to provide a novel infusion bag having advantages in the above respects.
- an infusion bag having an injection port for injecting a substance into an infusion liquid in the infusion bag, characterized in that: said injection port is closed by an elastomeric plug which is preformed with a slit for receiving a blunt cannula therethrough to inject said substance into said infusion bag, and which reseals itself after the blunt cannula has been removed: and in that said injection port further includes a separator layer on the inner face of the elastomeric plug, the separator layer being made of a material and of a thickness to be pierceable by a blunt cannula. but when not pierced, to prevent the infusion liquid from reaching and penetrating the slit during autoclaving of the infusion bag to sterilize the infusion liquid therein.
- the separator layer is preferably of polyethylene, po-yvinyl chloride, nyion or polypropylene: and is preferably of a thickness of 0.05 to 0.30 mm.
- the injection port is of a tubular configuration joined at its inner end to the infusion bag and formed at its outer end with an internal annular shoulder receiving the separator layer and the elastomeric plug thereover.
- the injection port further includes a cap applied over the outer end of the infusion port to retain the elastomeric plug and separator layer.
- the cap is formed with a central opening aligned with the slit to permit a blunt cannula to be inserted into the plug via the slit for injecting a substance into the infusion bag.
- the central opening in the cap is bordered by inwardly tapering sides of the cap to guide the blunt cannula to the slit.
- the outer end of the injection port is integrally formed with an intumed annular rim engaging the peripheral outer face of the elastomeric plug for retaining the plug and the separator layer.
- the infusion bag further includes a removable, tamper-proof foil applied over the outer face of the plug.
- an infusion bag constructed with the separator layer prevents the infusion liquid within the bag from reaching the elastomeric plug, and particularly from penetrating the slit, when the infusion bag is autoclaved to sterilize the infusion liquid.
- Such a construction thereby maintains the sterility of the infusion liquid, and the integrity of the elastomeric plug and slit, for the long shelf life required for such infusion bags.
- Fig. 1 illustrates one form of infusion bag constructed in accordance with the present invention
- Fig. 2 is an enlarged sectional view illustrating the construction of the injection port in the infusion bag of Fig. 1;
- Fig. 3 is an enlarged sectional view illustrating another construction of the injection port which may be used in the infusion bag of Fig. 1.
- the infusion bag illustrated in Fig. 1, and therein generally designated 2 is made of a pliable, transparent plastic material for receiving an infusion liquid, such as saline water.
- the bag is formed at one end with an opening 4 for suspending the bag at the time of administering the infusion liquid to a subject.
- the opposite end of the bag includes a tube defining an infusion port 6 for connection to an infusion tubing assembly through which the infusion liquid within the bag is administered to the subject.
- the infusion bag 2 further includes another tube 8 defining an injection port, generally designated 10, for injecting a substance into the infusion liquid within the bag, if so desired, before the infusion liquid is administered to the subject.
- the injection port 10 In the conventional infusion bag constructions, the injection port 10, sometimes called the injection site, is closed by an elastomeric plug or membrane pierced by a hypodermic needle at the time of injecting the substance into the bag.
- the injection port 10 In the construction illustrated in the drawings, the injection port 10 is closed by a pre-slitted elastomeric plug for receiving a blunt cannula to inject the substance into the infusion bag, to thereby reduce the danger of accidental infection by inadvertent contact with a contaminated hypodermic needle.
- Figs. 2 and 3 illustrate two constructions of the injection port 10 to solve this problem.
- the injection port 10 illustrated in Fig. 2 is applied to the outer end of tube 8 joined at its inner end to the infusion bag.
- Injection port 10 is formed at its outer end with an internal annular shoulder 11.
- Received on annular shoulder 11 are a separator layer 12, and thereover an elastomeric plug 13, such as of a rubber latex.
- Plug 13 is preformed with a slit 1-1- for receiving a blunt cannula (not shown) used to inject a substance into the infusion bag prior to administering the infusion liquid.
- Slit 14 may extend only partly through plug 13. e.g., terminating just short of its lower face, such that the slitted and unslitted parts are penetrated by the blunt cannula when inserted into the plug.
- slit 14 is formed completely through plug 13 to facilitate the insertion of the blunt cannula through the plug.
- Cap 15 is formed with a central opening 16 to permit a blunt cannula (not shown) to be inserted into and through plug 13 via its slit 14 for injecting a substance into the solution bag before the solution therein is administered to the subject. Opening 16 in the cap is bordered by inwardly tapering sides 17 of the cap to guide the blunt cannula to the slit 14.
- An annular seal 18 is provided between the inner surface of cap 15 and the outer surface of the outer end of the injection port 10.
- a removable tamper-proof foil 19 is applied over the outer face of cap 15.
- Separator 12 is made of a material and of a thickness which prevent the infusion liquid from reaching and penetrating the preformed slit 14 when the infusion bag is autoclaved at a high temperature (e.g., about 130 C) to sterilize the infusion liquid, but which enable the separator to be easily pierced by a blunt cannula if and when a substance is to be injected into the bag via the injection port.
- a particularly suitable material for this purpose is polyethylene of a thickness of 0.15 mm.
- Other materials that may be used are polyvinyl chloride, nylon and polypropylene. Generally, it is preferred to have this separator of a thickness of 0.05 to 0.30 mm.
- the separator layer 12 thus isolates the elastomeric plug 13 from the contents of the infusion bag, and therefore permits the infusion bag to be sterilized by autoclaving without danger that the steam produced during the process will reach the elastomeric plug, its preformed slit 14, or the infusion liquid within the bag.
- the separator layer therefore also maintains the integrity of the elastomeric plug and the slit for a long period of time after sterilization, and thereby maintains the sterile condition of the contents of the infusion bag, for the long shelf life, usually about two years, required for such infusion bags.
- the tamper-proof foil 19 further protects the plug and the contents of the infusion bag.
- Fig. 3 illustrates an alternative construction that may be used for the injection port, therein generally designated 20.
- the infusion port in Fig. 3 is also formed at its outer end with an internal annular shoulder 21 for receiving thereon the separator 22 and also the elastomeric plug 23, the latter being preformed with a slit 24 as described above with respect to Fig. 2.
- the separator layer and elastomeric plug are retained by an inturned annular rim 25 integrally formed at the outer end of the tubular injection port 20 and engaging the outer peripheral face of the elastomeric plug 23.
- Such a rim is
- a removable, tamper-proof foil 29 is applied over the outer face of the retainer rim 25 of the elastomeric plug 23.
- Fig. 3 The construction illustrated in Fig. 3 is otherwise the same, and provides the same advantages, as described above with respect to Fig. 2. While the invention has been described with respect to two preferred embodiments, it will be appreciated that these are set forth merely for purposes of example, and that many other variations, modifications and applications of the invention may be made.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU53558/96A AU5355896A (en) | 1995-02-27 | 1996-02-26 | Infusion bag with injection port |
EP96910333A EP0812158A4 (en) | 1995-02-27 | 1996-02-26 | Infusion bag with injection port |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11281695A IL112816A0 (en) | 1995-02-27 | 1995-02-27 | Infusion bag with injection port |
IL112816 | 1995-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996026681A1 true WO1996026681A1 (en) | 1996-09-06 |
Family
ID=11067140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/002580 WO1996026681A1 (en) | 1995-02-27 | 1996-02-26 | Infusion bag with injection port |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0812158A4 (en) |
AU (1) | AU5355896A (en) |
IL (1) | IL112816A0 (en) |
WO (1) | WO1996026681A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0925805A3 (en) * | 1997-12-23 | 1999-08-18 | Baxter International Inc. | Resealable access site for allowing a cannula multiple accesses to a fluid passageway |
EP0960616A3 (en) * | 1998-05-16 | 2000-04-26 | Bracco International B.V. | Multiple use universal stopper |
EP0974330A3 (en) * | 1998-07-20 | 2000-11-29 | Bracco International B.V. | Multiple use universal connector |
EP1384466A1 (en) * | 2002-07-23 | 2004-01-28 | Fresenius Kabi Deutschland GmbH | Plastics bottle for receiving a fluid, in particular an enteral nutritional solution |
CN101342114B (en) * | 2007-07-13 | 2012-03-21 | 株式会社迈蒂派 | Transfustion bag port with non-pvc material |
US8864725B2 (en) | 2009-03-17 | 2014-10-21 | Baxter Corporation Englewood | Hazardous drug handling system, apparatus and method |
US9353194B2 (en) | 2009-05-11 | 2016-05-31 | Teoxane | Process for preparing a crosslinked hyaluronic acid gel via homogenization in a deformable pouch |
WO2021118832A1 (en) * | 2019-12-12 | 2021-06-17 | Fresenius Medical Care Holdings, Inc. | An injection port for connecting with a medical fluid container and methods for the production of same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592092A (en) * | 1982-01-20 | 1986-05-27 | American Hospital Supply Corporation | Medical solution container and port construction therefor |
US4596573A (en) * | 1983-01-08 | 1986-06-24 | The Boots Company P.L.C. | Container |
US5188628A (en) * | 1990-11-06 | 1993-02-23 | Sandoz Ltd. | Closure device for enteral fluid containers |
US5211638A (en) * | 1988-01-25 | 1993-05-18 | Baxter International Inc. | Pre-slit injection site |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4119128A (en) * | 1977-02-18 | 1978-10-10 | Marilyn Bishop | Tamperproof sterile port cover and method of making same |
JPS5841964Y2 (en) * | 1979-05-18 | 1983-09-22 | テルモ株式会社 | plastic pharmaceutical liquid containers |
IL105251A (en) * | 1993-04-01 | 1996-03-31 | Travenol Lab Israel Ltd | Fluid coupling device and blunt cannula device particularly useful therewith |
JP3594604B2 (en) * | 1993-12-28 | 2004-12-02 | アボツト・ラボラトリーズ | Fluid port resealing member |
-
1995
- 1995-02-27 IL IL11281695A patent/IL112816A0/en unknown
-
1996
- 1996-02-26 AU AU53558/96A patent/AU5355896A/en not_active Abandoned
- 1996-02-26 WO PCT/US1996/002580 patent/WO1996026681A1/en not_active Application Discontinuation
- 1996-02-26 EP EP96910333A patent/EP0812158A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592092A (en) * | 1982-01-20 | 1986-05-27 | American Hospital Supply Corporation | Medical solution container and port construction therefor |
US4596573A (en) * | 1983-01-08 | 1986-06-24 | The Boots Company P.L.C. | Container |
US5211638A (en) * | 1988-01-25 | 1993-05-18 | Baxter International Inc. | Pre-slit injection site |
US5188628A (en) * | 1990-11-06 | 1993-02-23 | Sandoz Ltd. | Closure device for enteral fluid containers |
Non-Patent Citations (1)
Title |
---|
See also references of EP0812158A4 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0925805A3 (en) * | 1997-12-23 | 1999-08-18 | Baxter International Inc. | Resealable access site for allowing a cannula multiple accesses to a fluid passageway |
EP0960616A3 (en) * | 1998-05-16 | 2000-04-26 | Bracco International B.V. | Multiple use universal stopper |
EP0974330A3 (en) * | 1998-07-20 | 2000-11-29 | Bracco International B.V. | Multiple use universal connector |
EP1384466A1 (en) * | 2002-07-23 | 2004-01-28 | Fresenius Kabi Deutschland GmbH | Plastics bottle for receiving a fluid, in particular an enteral nutritional solution |
CN101342114B (en) * | 2007-07-13 | 2012-03-21 | 株式会社迈蒂派 | Transfustion bag port with non-pvc material |
US8864725B2 (en) | 2009-03-17 | 2014-10-21 | Baxter Corporation Englewood | Hazardous drug handling system, apparatus and method |
US9353194B2 (en) | 2009-05-11 | 2016-05-31 | Teoxane | Process for preparing a crosslinked hyaluronic acid gel via homogenization in a deformable pouch |
WO2021118832A1 (en) * | 2019-12-12 | 2021-06-17 | Fresenius Medical Care Holdings, Inc. | An injection port for connecting with a medical fluid container and methods for the production of same |
CN114867517A (en) * | 2019-12-12 | 2022-08-05 | 费森尤斯医疗保健控股公司 | Injection port for connection to a medical fluid container and method of making same |
Also Published As
Publication number | Publication date |
---|---|
AU5355896A (en) | 1996-09-18 |
EP0812158A1 (en) | 1997-12-17 |
IL112816A0 (en) | 1995-05-26 |
EP0812158A4 (en) | 1998-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5454805A (en) | Medicine vial link for needleless syringes | |
JP3694317B2 (en) | Port adapter and protector and container having them | |
US9108031B2 (en) | Connector having a membrane, for connecting a syringe to a container or tubing | |
US5100394A (en) | Pre-slit injection site | |
US5620434A (en) | Medicine vial link for needleless syringes | |
US5211638A (en) | Pre-slit injection site | |
JP3852672B2 (en) | Cap for container and adapter for liquid communication | |
US5776125A (en) | Needleless vial access device | |
US5135489A (en) | Pre-slit injection site and tapered cannula | |
CA1099230A (en) | Sterile connecting device | |
US20090270832A1 (en) | Needleless port assembly for a container | |
CA2071280A1 (en) | Transfer adaptors | |
KR980008252A (en) | Syringe Filling and Carrying Device | |
WO1996026681A1 (en) | Infusion bag with injection port | |
EP0820779B1 (en) | Syringe filling and delivery device | |
JP2006212084A (en) | Connector | |
JP2000126274A (en) | Drug mixing system and drug housing container | |
JP3949125B2 (en) | Multi-needle holder | |
JP2001178831A (en) | Connecting instrument and connecting tool for liquid medicine container | |
CA2094329A1 (en) | Flow adapter for drug vial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996910333 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996910333 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 875911 Date of ref document: 19971030 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996910333 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |